The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials

0 avis

The Net Chance of a Longer Survival as a Patient-Oriented Measure of Treatment Benefit in Randomized Clinical Trials

Archive ouverte

Péron, Julien | Roy, Pascal | Ozenne, B. | Roche, L. | Buyse, M.

Edité par CCSD ; American Medical Association -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Archive ouverte | Péron, Julien | CCSD

International audience

Assessing the benefit-risk of new treatments using generalised pairwise comparisons: the case of erlotinib in pancreatic cancer

Archive ouverte | Peron, Julien | CCSD

International audience. Background: Efficacy and safety are the two considerations when characterising the effects of a new therapy. We sought to apply an innovative method of assessing the benefit-risk balance usin...

Evaluation of Early Reperfusion Criteria in Acute Ischemic Stroke

Archive ouverte | Ozenne, B. | CCSD

International audience

Chargement des enrichissements...